Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Genetic disorders 8

Genetic Disorders

Pharma News and Updates for BMS, Biogen, Merck, Moderna, and Takeda

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Bristol Myers’ Opdivo combo Opdualag for Melanoma; Biogen’s Aduhelm; Marinus’ Ztalmy for CDKL-5 Deficiency Disorder; Merck’s Keytruda + Lynparza; Vitaris’s Breyna; Moderna’s Second COVID-19 Booster Shot; Takeda’s Exkivity; BMS’s First LAG-3 Checkpoint Inhibitor

NHS Grants Fast Track Access to Takeda’s Exkivity Takeda has secured UK approval for its lung cancer therapy Exkivity, with an NHS access deal that could see it prescribed to patients within the next few weeks. The Medicines and Healthcare products Regulatory Agency has granted conditional marketing authorisation to Exkivity as monotherapy for non-small-cell lung cancer patients. At the same time, NHS England, cost-effectiveness watchdog NICE and Takeda have agreed on an early access deal for the drug that includes a discount on its monthly cost of around $25,000. According to Sajid Javid, Secretary of Health and Social Care, Exkivity will be available to ...

Explore More...

Down Syndrome Awareness Month

Down Syndrome Awareness Month

Batten Disease market

Batten Disease Market: Barriers and Growth Opportunities

Pharma News

Flagship Pioneering launches Omega Therapeutics; EU nod to Vitrakvi; Bluebird Bio reveals positive results of Starbeam clinical trial

Spinal Muscular Atrophy Therapies

How Spinal Muscular Atrophy Therapies transform market?

Niemann–Pick disease type C Therapeutics Market

pharma News

CHPM’s positive approval for 13 Medicines; NICE approval for AstraZeneca’s Olaparib; Exact Sciences to buy Genomic Health

Recent Pharma News

Recursion Pharmaceuticals nets USD 121M; Bayer’s MRI agent gets a nod

Gene Therapy

The era of Gene therapy, and the Billion Dollar tag

sickle cell day

World Sickle Cell Day

Huntington's disease

Origins of the depressive behaviour in Huntington’s disease

Autism

What is causing a rise in Autism rate?

Meet the World’s most expensive drug: Zolgensma

Antitrypsin Deficiency Pipeline

Antitrypsin Deficiency Pipeline

Antitrypsin deficiency

Unmet Needs in the treatment of Antitrypsin deficiency

AstraZeneca-Daiichi’s results; Novartis remunerates; Pfizer to acquire Therachon; Gilead & Goldfinch Bio collaboration

Spinal Muscular Atrophy

Spinal Muscular Atrophy Market

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly